Şanal Laser, Günaydın Serdar, Tatar Mehtap
Transfusion Center, Ministry of Health, Ankara Bilkent City Hospital Campus, Ankara, Turkey.
Department of Cardiovascular Surgery, University of Health Sciences, Ankara Bilkent City Hospital Campus, Ankara, Turkey.
Adv Ther. 2024 Feb;41(2):716-729. doi: 10.1007/s12325-023-02733-5. Epub 2023 Dec 19.
Anemia and transfusion of blood products are risk factors associated with poor patient outcomes across all elective surgeries. Patient blood management (PBM) is a patient-centered approach to optimize patient's endogenous red cell mass, to minimize blood loss in patients undergoing surgery, and to harness and optimize patient-specific physiological tolerance to anemia. This study aimed to assess (1) the impact of PBM on blood product usage in cardiovascular surgeries in a state hospital setting, (2) cost-effectiveness of PBM with a model based on transfusion of red blood cells (RBCs) in cardiovascular surgeries, and (3) the budget impact of PBM implementation based on transfusion of RBCs.
Cost-effectiveness and budget impact models, based on the numbers of avoided transfusions and avoided complications after implementation of the PBM program, were compared between pre- and post-PBM periods at the cardiovascular surgery department of Ankara Bilkent City Hospital between February 11, 2019 and July 24, 2022. The probabilities of transfusions and complications with and without PBM were taken from recent meta-analyses. Data from the Ankara Bilkent City Hospital transfusion center informed the pre- and post-PBM calculations. Costs were calculated from the Social Security Institution's perspective.
There was a 21% decrease in the use of RBCs and a 23.7% decrease in use of all blood products after the implementation of PBM. The number of RBC packs per patient reduced by 0.88 packs (21%). The cost saving from reduction of RBC transfusions per patient was 518.68 Turkish lira (TRY) and for the hospital it was 1,635,948 TRY. Fewer complications and lower costs in favor of the post-PBM arm were demonstrated in the cost-effectiveness analysis. On the basis of the budget impact model, in 20 months, the hospital's cardiovascular surgery department saved 6,596,934 TRY (€342,302).
This hospital-based study demonstrated that PBM is a budget-saving and cost-effective option in Turkey.
贫血和输血是所有择期手术中与患者不良预后相关的危险因素。患者血液管理(PBM)是一种以患者为中心的方法,旨在优化患者的内源性红细胞量,减少手术患者的失血量,并利用和优化患者对贫血的特定生理耐受性。本研究旨在评估:(1)PBM对一家公立医院心血管手术中血液制品使用的影响;(2)基于心血管手术中红细胞(RBC)输注的模型评估PBM的成本效益;(3)基于RBC输注的PBM实施对预算的影响。
在2019年2月11日至2022年7月24日期间,比较安卡拉比尔肯特市医院心血管外科在实施PBM计划前后基于避免输血次数和避免并发症数量的成本效益模型和预算影响模型。有无PBM时输血和并发症的概率来自近期的荟萃分析。安卡拉比尔肯特市医院输血中心的数据为PBM实施前后的计算提供了依据。成本从社会保障机构的角度进行计算。
实施PBM后,RBC的使用量减少了21%,所有血液制品的使用量减少了23.7%。每位患者的RBC包数减少了0.88包(21%)。每位患者因减少RBC输血而节省的成本为518.68土耳其里拉(TRY),对医院而言为1,635,948 TRY。成本效益分析表明,PBM实施后并发症更少且成本更低。基于预算影响模型,在20个月内,医院的心血管外科节省了6,596,934 TRY(342,302欧元)。
这项基于医院的研究表明,PBM在土耳其是一种节省预算且具有成本效益的选择。